NCCN Risk Reclassification in Black Men with Low and Intermediate Risk Prostate Cancer After Genomic Testing
Seiden B, Weng S, Sun N, Gordon D, Harris W, Barnett J, Myrie A, Jones T, Pak S, Fudl A, Shields J, McNeil B, Weiss J, Smith M, Esdaille A, Winer A. NCCN Risk Reclassification in Black Men with Low and Intermediate Risk Prostate Cancer After Genomic Testing. Urology 2021, 163: 81-89. PMID: 34688772, DOI: 10.1016/j.urology.2021.08.055.Peer-Reviewed Original ResearchConceptsNCCN riskIntermediate riskGenomic testingLower riskPre-biopsy prostate specific antigenNational Comprehensive Cancer Network guidelinesIntermediate-risk prostate cancerFavorable intermediate riskNCCN risk classificationPre-biopsy PSARisk classificationRisk prostate cancerUnfavorable intermediate riskProstate-specific antigenInitial risk classificationMedian ageBlack patientsNetwork guidelinesActive surveillanceProstate cancerHigher oddsSpecific antigenNonparametric statistical testingPatientsRiskRacial Differences in Incident Genitourinary Cancer Cases Captured in the National Cancer Database
Wolff D, Monaghan T, Gordon D, Michelson K, Jones T, Khargi R, Smith M, Maffucci F, Kwun H, Suss N, Winer A. Racial Differences in Incident Genitourinary Cancer Cases Captured in the National Cancer Database. Medicina 2021, 57: 671. PMID: 34209546, PMCID: PMC8303448, DOI: 10.3390/medicina57070671.Peer-Reviewed Original ResearchConceptsNational Cancer DatabaseGenitourinary cancersBladder cancerCancer DatabaseProstate cancerCancer casesKidney cancerPrimary tumor locationPatient demographic factorsNew cancer diagnosesCoverage ratePenile cancerBlack patientsGenitourinary malignanciesTesticular cancerTumor locationMajor cancersHealth equity researchCancerWhite subjectsCancer diagnosisLow coverage rateWhite femalesRacial differences